SCHEMBL2196932

SCHEMBL2196932

COc1ccc(Cl)c(C(O)c2ccc(Br)cc2Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.40
SLC6A4 P31645 3/20 0.40
KCNH2 Q12809 3/20 0.40
MAPT P10636 5/20 0.40
NPSR1 Q6W5P4 2/20 0.40
PKM P14618 1/20 0.39
ADRA2A P08913 2/20 0.38
ADRA1A P35348 2/20 0.38
CYP2D6 P10635 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
APLNR P35414 2/20 0.36
MAPK1 P28482 2/20 0.36
BLM P54132 1/20 0.36
FLT3 P36888 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786266 0.76 MAPT (0.46) HTR2ASLC6A4KCNH2MAPTADRA2A
SCHEMBL14955179 0.73 MAPT (0.36) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL30438867 0.73 AOC3 (0.47) HTR2APKMADRA2AADRA1ALMNA
SCHEMBL23457049 0.72 ADRA2A (0.47) MAPTADRA2AADRA1ACYP2D6MEN1
SCHEMBL31682604 0.72 ADRA2A (0.47) MAPTADRA2AADRA1ACYP2D6MEN1
SCHEMBL2199411 0.71 THRB (0.43) SLC6A4MAPTADRA2AADRA1AMEN1
SCHEMBL31063011 0.71 CYP2D6 (0.50) HTR2ASLC6A4KCNH2ADRA2AADRA1A
SCHEMBL474013 0.71 PDE2A (0.51) HTR2ASLC6A4KCNH2ADRA2AADRA1A
SCHEMBL2199635 0.71 APLNR (0.40) APLNR
SCHEMBL2698362 0.70 PDE2A (0.55) NPSR1MEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 HTR2A 4095/4885SLC6A4 4387/4885KCNH2 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.